| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Disparities in Liver Transplantation for Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Associated Hepatocellular Carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
David W Victor, Sudha Kodali, Mazen Noureddin, Elizabeth W Brombosz, Analisa Lopez, Tamneet Basra, Edward A Graviss, Duc T Nguyen, Ashish Saharia, Ashton A Connor, Maen Abdelrahim, Yee Lee Cheah, Caroline J Simon, Mark J Hobeika, Constance M Mobley and R Mark Ghobrial |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
David W Victor, Director, MD, Sherrie and Alan Conover Center for Liver Disease and Transplantation, Department of Medicine, Houston Methodist Hospital, 6550 Fannin Street, Houston, TX 77030, United States. dwvictor@houstonmethodist.org |
| Key Words |
Steatotic liver disease; Liver neoplasms; Ethnic and racial minorities; Healthcare disparities; Minority health |
| Core Tip |
Ethnicity, sex, and geographic region affect access to liver transplantation for hepatocellular carcinoma in the background of metabolic dysfunction-associated steatohepatitis, highlighting the need for strategies to address these discrepancies. |
| Publish Date |
2025-04-18 08:22 |
| Citation |
<p>Victor DW, Kodali S, Noureddin M, Brombosz EW, Lopez A, Basra T, Graviss EA, Nguyen DT, Saharia A, Connor AA, Abdelrahim M, Cheah YL, Simon CJ, Hobeika MJ, Mobley CM, Ghobrial RM. Disparities in Liver Transplantation for Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Associated Hepatocellular Carcinoma. <i>World J Transplant</i> 2025; 15(3): 101997</p> |
| URL |
https://www.wjgnet.com/2220-3230/full/v15/i3/101997.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v15.i3.101997 |
